EP4194464A1 — Manufacturing process for the production of linaclotide
Assigned to Chemi SpA · Expires 2023-06-14 · 3y expired
What this patent protects
The present invention relates to a manufacturing process to produce Linaclotide and its acetate, more particularly, to obtain High-Purity Linaclotide or its acetate with a chromatographic purity equal to or higher than 99.9%.The invention further relates to an analytical RP-HPLC …
USPTO Abstract
The present invention relates to a manufacturing process to produce Linaclotide and its acetate, more particularly, to obtain High-Purity Linaclotide or its acetate with a chromatographic purity equal to or higher than 99.9%.The invention further relates to an analytical RP-HPLC method to analyze said product.
Drugs covered by this patent
- Linzess (LINACLOTIDE) · AbbVie
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.